Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Research Opportunity: DNA-Protein Epigenetic Chemistry…

U.S. Department Of Defense·Virginia

Research Opportunity: DNA-Protein Epigenetic Chemistry Engineering (D-PECHE)

Closes 6/24/2026$500k – $2MRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals to demonstrate proof-of-concept for novel mechanisms for writing and erasing epigenetic base modifications in DNA. The goal of the effort is to develop novel methods of modifying DNA bases in living cells and validate the presence of new base modifications catalyzed in vitro. Key aspects of the project include: • Developing novel mechanisms for writing and erasing epigenetic base modifications in DNA • Validating the presence of new base modifications catalyzed in vitro • Demonstrating the ability to design DNA-modifying mechanisms to write and/or erase DNA base modifications • Detecting DNA modifications in vitro and demonstrating biocompatibility of targeted modification in host cell line • Developing assays to detect base modifications and establishing approaches to detect novel modifications in cells

Attached files

Contact

Dr. Aric Lu(Technical Point of Contact)

[email protected]

Key dates

Opened
5/6/2026
Questions due
5/20/2026
Closes
6/24/2026
Duration
4 months

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
541714
Solicitation №
DARPA-SN-26-67

Budget estimate

$500,000 – $2,000,000

The budget for this project can be estimated based on the proposed costs, which should not exceed $2,000,000 for the accelerated award option. The actual budget will depend on the quality of the submissions received and the availability of funds. Factors that may influence the likely payment range include the complexity of the project, the number of awards made, and the amount of funding available.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Defense·Maryland

Top match · 71%

Notice of Intent DNA Synthesizer

Closes 11/2/2026Opened 10/15/2026

U.S. National Institutes of Health·United States of America

70% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

69% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. Department Of Energy·Ohio

68% match

TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation

Closes 12/22/2026Opened 6/22/2026

U.S. National Institutes of Health·United States of America

68% match

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

Closes 1/11/2027Opened 1/20/2026

U.S. Department Of Energy·Ohio

68% match

TECHNOLOGY LICENSING OPPORTUNITY: SignalGen

Closes 3/22/2027Opened 9/22/2026

U.S. Department Of The Interior·United States of America

68% match

Q--MOJAVE TORTOISE BIOINFORMATICS

Closes 10/31/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

67% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Science Foundation·United States of America

67% match

MPS Chemistry Research Programs (MPS Chem)

Closes 10/7/2076Opened 8/17/2026

U.S. National Institutes of Health·United States of America

67% match

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

U.S. Office of Science·United States of America

66% match

The Genesis Mission: Transforming Science and Energy with AI

Closes 12/17/2026Opened 3/17/2026

U.S. National Institutes of Health·United States of America

66% match

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. Department Of Defense·Virginia

66% match

High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)

Closes 11/5/2026Opened 10/8/2026

U.S. National Institutes of Health·United States of America

66% match

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 10/28/2024

U.S. National Science Foundation·United States of America

66% match

Division of Chemistry: Disciplinary Research Programs (CHE-DRP)

Rolling / TBD closeOpened 4/26/2023

U.S. National Institutes of Health·United States of America

66% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

66% match

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

66% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025

U.S. National Institutes of Health·United States of America

66% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

66% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. Department Of Energy·Ohio

66% match

TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro

Closes 12/5/2026Opened 6/5/2026

U.S. National Institutes of Health·United States of America

66% match

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 8/13/2024

U.S. National Institutes of Health·United States of America

66% match

RNomics Technology Enhancement Centers

Closes 1/31/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

66% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

National Science Foundation·Virginia

66% match

NSF X-Labs Initiative - From Sequence to Function

Closes 2/8/2027Opened 10/14/2026